Integrative Immunogenomic Profiling of Triple-Negative Breast Cancer to Identify Novel Neoantigen Targets for Personalized Checkpoint Inhibitor Therapy and Tumor Microenvironment Reprogramming.
Author: Supria Rani Pal LG-ID: 27199320190101927 Mail Address Publication No: 397488 Type: Original | Open Access Category: Health & Medical Received: September 17, 2024 Accepted: November 29, 2024 Published: January 24, 2025 Sections Abstract Introduction Literature Review Methodology Results Discussion Conclusion References Abstract Triple-negative breast cancer (TNBC) makes up about 15–20% of all breast cancer […]